NONHUMAN PRIMATE MODEL FOR TB VACCINES

结核病疫苗的非人类灵长类动物模型

• 批准号: 7959046
• 负责人: Paul Luciw
• 金额: $ 7.12万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7959046
• 关键词: Antitubercular Agents; California; Clinical; Computer Retrieval of Information on Scientific Projects Database; Drug Formulations; Funding; Grant; Institution; Macaca; Macaca mulatta; Modeling; Mycobacterium tuberculosis; Primates; Research; Research Personnel; Resources; Source; Tuberculosis; Tuberculosis Vaccines; United States National Institutes of Health; nonhuman primate; novel

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Macaques experimentally inoculated with Mycobacterium tuberculosis (M.tb.) show clinical signs of tuberculosis (TB). This project will evaluate novel anti-tuberculosis vaccine formulations for efficacy in rhesus macaques.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 实验性接种结核分枝杆菌（M.tb.）显示结核病（TB）的临床症状。 该项目将评估新型抗结核疫苗制剂在恒河猴中的有效性。